BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

301 related articles for article (PubMed ID: 35628352)

  • 1. Design and Development of a New Type of Hybrid PLGA/Lipid Nanoparticle as an Ursolic Acid Delivery System against Pancreatic Ductal Adenocarcinoma Cells.
    Markowski A; Jaromin A; Migdał P; Olczak E; Zygmunt A; Zaremba-Czogalla M; Pawlik K; Gubernator J
    Int J Mol Sci; 2022 May; 23(10):. PubMed ID: 35628352
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of the In Vitro Cytotoxic Activity of Ursolic Acid PLGA Nanoparticles against Pancreatic Ductal Adenocarcinoma Cell Lines.
    Markowski A; Migdał P; Zygmunt A; Zaremba-Czogalla M; Gubernator J
    Materials (Basel); 2021 Aug; 14(17):. PubMed ID: 34501007
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of pancreatic ductal adenocarcinoma with tumor antigen specific-targeted delivery of paclitaxel loaded PLGA nanoparticles.
    Wu ST; Fowler AJ; Garmon CB; Fessler AB; Ogle JD; Grover KR; Allen BC; Williams CD; Zhou R; Yazdanifar M; Ogle CA; Mukherjee P
    BMC Cancer; 2018 Apr; 18(1):457. PubMed ID: 29685122
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ursolic Acid Loaded PLGA Nanoparticles: in vitro and in vivo Evaluation to Explore Tumor Targeting Ability on B16F10 Melanoma Cell Lines.
    Baishya R; Nayak DK; Kumar D; Sinha S; Gupta A; Ganguly S; Debnath MC
    Pharm Res; 2016 Nov; 33(11):2691-703. PubMed ID: 27431865
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improved drug loading and antibacterial activity of minocycline-loaded PLGA nanoparticles prepared by solid/oil/water ion pairing method.
    Kashi TS; Eskandarion S; Esfandyari-Manesh M; Marashi SM; Samadi N; Fatemi SM; Atyabi F; Eshraghi S; Dinarvand R
    Int J Nanomedicine; 2012; 7():221-34. PubMed ID: 22275837
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Magnetic core-shell nanoparticles for drug delivery by nebulization.
    Verma NK; Crosbie-Staunton K; Satti A; Gallagher S; Ryan KB; Doody T; McAtamney C; MacLoughlin R; Galvin P; Burke CS; Volkov Y; Gun'ko YK
    J Nanobiotechnology; 2013 Jan; 11():1. PubMed ID: 23343139
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Engineering the lipid layer of lipid-PLGA hybrid nanoparticles for enhanced in vitro cellular uptake and improved stability.
    Hu Y; Hoerle R; Ehrich M; Zhang C
    Acta Biomater; 2015 Dec; 28():149-159. PubMed ID: 26428192
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activation of polymeric nanoparticle intracellular targeting overcomes chemodrug resistance in human primary patient breast cancer cells.
    Abou-El-Naga AM; Mutawa G; El-Sherbiny IM; Mousa SA
    Int J Nanomedicine; 2018; 13():8153-8164. PubMed ID: 30555232
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of 6-Thioguanine conjugated PLGA nanoparticles through thioester bond formation: Benefits of electrospray mediated drug encapsulation and sustained release in cancer therapeutic applications.
    Chatterjee M; Jaiswal N; Hens A; Mahata N; Chanda N
    Mater Sci Eng C Mater Biol Appl; 2020 Sep; 114():111029. PubMed ID: 32994006
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design of Astaxanthin-Loaded Core-Shell Nanoparticles Consisting of Chitosan Oligosaccharides and Poly(lactic- co-glycolic acid): Enhancement of Water Solubility, Stability, and Bioavailability.
    Liu C; Zhang S; McClements DJ; Wang D; Xu Y
    J Agric Food Chem; 2019 May; 67(18):5113-5121. PubMed ID: 31013074
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis, characterization, and evaluation of paclitaxel loaded in six-arm star-shaped poly(lactic-co-glycolic acid).
    Chen Y; Yang Z; Liu C; Wang C; Zhao S; Yang J; Sun H; Zhang Z; Kong D; Song C
    Int J Nanomedicine; 2013; 8():4315-26. PubMed ID: 24235829
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preparation and Characterization of PLGA-based Magnetic Polymer Nanoparticles for Targeting Pancreatic Adenocarcinoma.
    Lu L; Jie L; Zhou Y; Zhang J; Feng T; Zhu Y; Chen T; Zhu X; Ji J; Wang Z
    Curr Pharm Des; 2023; 29(9):686-696. PubMed ID: 36967466
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preferential tumor accumulation and desirable interstitial penetration of poly(lactic-co-glycolic acid) nanoparticles with dual coating of chitosan oligosaccharide and polyethylene glycol-poly(D,L-lactic acid).
    Wang G; Chen Y; Wang P; Wang Y; Hong H; Li Y; Qian J; Yuan Y; Yu B; Liu C
    Acta Biomater; 2016 Jan; 29():248-260. PubMed ID: 26476340
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oral delivery of topotecan in polymeric nanoparticles: Lymphatic distribution and pharmacokinetics.
    Jeong SH; Jang JH; Lee YB
    J Control Release; 2021 Jul; 335():86-102. PubMed ID: 34015399
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro evaluation of 5-aminolevulinic acid (ALA) loaded PLGA nanoparticles.
    Shi L; Wang X; Zhao F; Luan H; Tu Q; Huang Z; Wang H; Wang H
    Int J Nanomedicine; 2013; 8():2669-76. PubMed ID: 23926429
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PEG-lipid-PLGA hybrid nanoparticles loaded with berberine-phospholipid complex to facilitate the oral delivery efficiency.
    Yu F; Ao M; Zheng X; Li N; Xia J; Li Y; Li D; Hou Z; Qi Z; Chen XD
    Drug Deliv; 2017 Nov; 24(1):825-833. PubMed ID: 28509588
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Computational design of Phe-Tyr dipeptide and preparation, characterization, cytotoxicity studies of Phe-Tyr dipeptide loaded PLGA nanoparticles for the treatment of hypertension.
    Kecel-Gündüz S; Budama-Kilinc Y; Cakir Koc R; Kökcü Y; Bicak B; Aslan B; Özel AE
    J Biomol Struct Dyn; 2018 Aug; 36(11):2893-2907. PubMed ID: 28835169
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lipoparticles for Synergistic Chemo-Photodynamic Therapy to Ovarian Carcinoma Cells: In vitro and in vivo Assessments.
    Ali S; Amin MU; Tariq I; Sohail MF; Ali MY; Preis E; Ambreen G; Pinnapireddy SR; Jedelská J; Schäfer J; Bakowsky U
    Int J Nanomedicine; 2021; 16():951-976. PubMed ID: 33603362
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Surface modification of PLGA nanoparticles via human serum albumin conjugation for controlled delivery of docetaxel.
    Manoochehri S; Darvishi B; Kamalinia G; Amini M; Fallah M; Ostad SN; Atyabi F; Dinarvand R
    Daru; 2013 Jul; 21(1):58. PubMed ID: 23866721
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Polymer-lipid-PEG hybrid nanoparticles as photosensitizer carrier for photodynamic therapy.
    Pramual S; Lirdprapamongkol K; Svasti J; Bergkvist M; Jouan-Hureaux V; Arnoux P; Frochot C; Barberi-Heyob M; Niamsiri N
    J Photochem Photobiol B; 2017 Aug; 173():12-22. PubMed ID: 28554072
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.